Identification and characteristics of patients with potential difficult-to-treat Psoriatic Arthritis: exploratory analyses of the Greek PsA registry.

axial-disease difficult-to-treat (D2T) psoriasis psoriatic arthritis refractory

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 13 02 2024
revised: 11 04 2024
accepted: 22 04 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: aheadofprint

Résumé

To present the characteristics of patients with potential difficult-to-treat (D2T) psoriatic arthritis (PsA). We used data from the Greek multicentre registry of PsA patients. D2T-PsA was defined as follows: patients with at least 6-months disease duration, who have failed to at least 1 csDMARD and at least 2 bDMARDs/tsDMARDs with a different mechanism of action and have either at least moderate disease activity (MODA) defined as DAPSA > 14, and/or are not at minimal disease activity (MDA). Demographic and clinical characteristics were compared between D2T and non-D2T PsA patients. In two sensitivity analyses, patients classified as D2T solely according to the MODA or MDA criterion were examined separately. Among 467 patients included, 77 (16.5%) were considered D2T and 390 non-D2T PsA. Compared with non-D2T, patients with D2T PsA presented more commonly with extensive psoriasis (p< 0.0001) and were more likely to have higher BMI (p= 0.023) and a history of inflammatory bowel disease (p= 0.026). In the MODA and MDA sensitivity analyses, 7.5% and 12.5% of patients were considered D2T, respectively. In both sensitivity analyses, extensive psoriasis was again identified as an independent variable for D2T PsA (p= 0.001 and p= 0.008, respectively). Moreover, female gender (p= 0.034) in the MODA analysis and axial disease (p= 0.040) in the MDA analysis were independent variables for D2T PsA. Despite the availability of therapies, D2T PsA is common in real-life cohorts of patients with PsA and extensive psoriasis. High BMI, female gender, axial-disease, and history of IBD were also associated with D2T PsA.

Identifiants

pubmed: 38759119
pii: 7676132
doi: 10.1093/rheumatology/keae263
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Auteurs

Konstantinos D Vassilakis (KD)

Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Charalampos Papagoras (C)

First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

Nikolaos Fytanidis (N)

First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

Sousana Gazi (S)

Department of Rheumatology, KAT Hospital, Athens, Greece.

Evangelia Mole (E)

Department of Rheumatology, KAT Hospital, Athens, Greece.

Michael Krikelis (M)

Department of Rheumatology, KAT Hospital, Athens, Greece.

Paraskevi V Voulgari (PV)

Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina.

Evripidis Kaltsonoudis (E)

Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina.

Nikolaos Koletsos (N)

Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina.

Dimitrios Boumpas (D)

Joint Academic Rheumatology Program, 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Pelagia Katsimpri (P)

Joint Academic Rheumatology Program, 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Dimitrios Katsifis-Nezis (D)

Joint Academic Rheumatology Program, 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Theodoros Dimitroulas (T)

4th Department of Medicine, Aristotle University, Thessaloniki, Greece.

Nikolaos Kougkas (N)

4th Department of Medicine, Aristotle University, Thessaloniki, Greece.

Maria Boutel (M)

4th Department of Medicine, Aristotle University, Thessaloniki, Greece.

Petros P Sfikakis (PP)

Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Maria G Tektonidou (MG)

Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Chrysoula Gialouri (C)

Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Dimitrios Bogdanos (D)

Department of Rheumatology and Clinical Immunology, University of Thessaly, Larissa, Greece.

Theodora Simopoulou (T)

Department of Rheumatology and Clinical Immunology, University of Thessaly, Larissa, Greece.

Christos Koutsianas (C)

Joint Academic Rheumatology Program, Clinical Immunology, Rheumatology unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens Medical School, General Hospital of Athens "Hippokration", Athens, Greece.

Evgenia Mavrea (E)

Joint Academic Rheumatology Program, Clinical Immunology, Rheumatology unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens Medical School, General Hospital of Athens "Hippokration", Athens, Greece.

Gkikas Katsifis (G)

Rheumatology Clinic, Naval Hospital of Athens, Athens, Greece.

Konstantinos Kottas (K)

Rheumatology Clinic, Naval Hospital of Athens, Athens, Greece.

Maria Konsta (M)

Rheumatology Unit, Sismanoglio Hospital, Athens, Greece.

Matthoula Tziafalia (M)

Rheumatology Unit, Sismanoglio Hospital, Athens, Greece.

Evangelia Kataxaki (E)

Rheumatology Department, General Hospital Elefsinas Thriaseio, Athens, Greece.

Eleni Kalavri (E)

Department of Rheumatology, "Asklepieion" General Hospital, Athens, Greece.

Kalliopi Klavdianou (K)

Department of Rheumatology, "Asklepieion" General Hospital, Athens, Greece.

Eleftheria P Grika (EP)

Department of Rheumatology, Evaggelismos Athens General Hospital, Athens, Greece.

Charalampos Sfontouris (C)

Department of Rheumatology, Evaggelismos Athens General Hospital, Athens, Greece.

Dimitrios Daoussis (D)

Department of Rheumatology, Patras University Hospital, University of Patras Medical School, Patras, Greece.

George Iliopoulos (G)

Department of Rheumatology, Patras University Hospital, University of Patras Medical School, Patras, Greece.

Ilias Bournazos (I)

Private practice, Athens, Greece.

Dimitrios Karokis (D)

Private practice, Athens, Greece.

Konstantinos Georganas (K)

Private practice, Athens, Greece.

Dimos Patrikos (D)

Private practice, Athens, Greece.

Dimitrios Vassilopoulos (D)

Joint Academic Rheumatology Program, Clinical Immunology, Rheumatology unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens Medical School, General Hospital of Athens "Hippokration", Athens, Greece.

George E Fragoulis (GE)

Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Classifications MeSH